亚太地区医疗外骨骼市场预测至 2031 年 - 区域分析 - 按组件(硬件和软件)、类型(动力外骨骼和被动外骨骼)、肢体(下肢外骨骼、上肢外骨骼和全身外骨骼)、应用(脊髓损伤、多发性硬化症、中风、脑瘫、帕金森病等)、移动性(移动外骨骼和固定外骨骼)和最终用户(康复中心、理疗中心、长期护理中心、家庭护理环境等)

Historic Data: 2020-2021   |   Base Year: 2023   |   Forecast Period: 2023-2031


No. of Pages: 120    |    Report Code: BMIRE00031139    |    Category: Life Sciences

Asia Pacific Medical Exoskeleton Market
2023 年亚太地区医疗外骨骼市场价值为 7643 万美元,预计到 2031 年将达到 7.202 亿美元;预计 2023 年至 2031 年的复合年增长率为 32.4%。

SCI 患病率不断上升推动亚太地区医疗外骨骼市场发展

身体活动减少和坐姿活动占主导地位会导致 SCI 患者严重的身心恶化。与 SCI 相关的继发性并发症也会缩短预期寿命。根据美国国家医学图书馆的数据,全球每年有近 250,000-500,000 名患者患有 SCI。根据美国国立卫生研究院的报告,病例数量的增加归因于越野摩托车和摩托车比赛成为全球最受欢迎的体育活动。根据世界卫生组织的数据,全球每年约有 119 万人死于道路交通事故,2000 万至 5000 万人遭受非致命伤害,其中许多人致残。Lifeward 等公司正致力于开发外骨骼,帮助 SCI 患者无痛地进行身体活动。例如,大约 20% 的 SCI 患者可以被视为当前 ReWalk 个人外骨骼或 ReWalk 康复外骨骼临床试验的候选人。此外,医疗外骨骼中的软外骨骼装置可用于 SCI 患者。因此,SCI 患病率的增加和针对 SCI 患者使用外骨骼的持续研究有望在预测期内推动市场增长。

亚太医疗外骨骼市场概览

亚太地区的医疗外骨骼市场细分为马来西亚、泰国、印度、新加坡、菲律宾、越南、印度尼西亚、中国、日本、澳大利亚、韩国和亚太地区其他地区。老年人口不断增加、慢性病不断增加、技术不断进步以及初创企业数量激增是该地区市场发展的有利因素。

亚太地区医疗外骨骼市场收入及预测至 2031 年(百万美元)

亚太地区医疗外骨骼市场细分

亚太地区医疗外骨骼市场分为组件、类型、肢体、应用、移动性、最终用户和国家。

按组件,亚太地区医疗外骨骼市场分为硬件和软件。 2023 年,硬件部分在亚太医疗外骨骼市场占有较大份额。

就类型而言,亚太医疗外骨骼市场分为动力外骨骼和被动外骨骼。2023 年,动力外骨骼部分在亚太医疗外骨骼市场占有较大份额。

根据肢体,亚太医疗外骨骼市场细分为下半身外骨骼、上半身外骨骼和全身外骨骼。2023 年,下半身外骨骼部分在亚太医疗外骨骼市场占有最大份额。

按应用,亚太医疗外骨骼市场细分为脊髓损伤、多发性硬化症、中风、脑瘫、帕金森病等。脊髓损伤部分在 2023 年占据了亚太地区医疗外骨骼市场份额的最大份额。

就移动性而言,亚太地区医疗外骨骼市场分为移动外骨骼和固定外骨骼。动力外骨骼部分在 2023 年占据了亚太地区医疗外骨骼市场份额的较大份额。

按最终用户划分,亚太地区医疗外骨骼市场分为康复中心、理疗中心、长期护理中心、家庭护理环境等。康复中心部分在 2023 年占据了亚太地区医疗外骨骼市场份额的最大份额。

根据国家/地区,亚太地区医疗外骨骼市场分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。 2023 年,日本占据了亚太医疗外骨骼市场的最大份额。

BIONIK;B-Temia Inc;Cyberdyne Inc;Ekso Bionics Holdings Inc;ExoAtlet;Hocoma AG;Lifeward, Inc;Myomo Inc;和 Rex Bionics Ltd. 是亚太医疗外骨骼市场的一些领先公司。

Asia Pacific Medical Exoskeleton Strategic Insights

Strategic insights for Asia Pacific Medical Exoskeleton involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-medical-exoskeleton-market-strategic-framework.webp
Get more information on this report

Asia Pacific Medical Exoskeleton Report Scope

Report Attribute Details
Market size in 2023 US$ 76.43 Million
Market Size by 2031 US$ 720.20 Million
Global CAGR (2023 - 2031) 32.4%
Historical Data 2020-2021
Forecast period 2023-2031
Segments Covered By 组件
  • 硬件和软件
By 类型
  • 动力外骨骼和被动外骨骼
By 肢体
  • 下肢外骨骼
  • 上肢外骨骼
  • 全身外骨骼
By 应用
  • 脊髓损伤
  • 多发性硬化症
  • 中风
  • 脑瘫
  • 帕金森病
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Myomo Inc
  • Rex Bionics Ltd.
  • Get more information on this report

    Asia Pacific Medical Exoskeleton Regional Insights

    The regional scope of Asia Pacific Medical Exoskeleton refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-medical-exoskeleton-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Medical Exoskeleton Market

    • Ekso Bionics Holdings Inc
    • Lifeward, Inc
    • ExoAtlet
    • Cyberdyne Inc
    • BIONIK
    • B-Temia Inc
    • Hocoma AG
    • Myomo Inc
    • Rex Bionics Ltd.
    Frequently Asked Questions
    How big is the Asia Pacific Medical Exoskeleton Market?

    The Asia Pacific Medical Exoskeleton Market is valued at US$ 76.43 Million in 2023, it is projected to reach US$ 720.20 Million by 2031.

    What is the CAGR for Asia Pacific Medical Exoskeleton Market by (2023 - 2031)?

    As per our report Asia Pacific Medical Exoskeleton Market, the market size is valued at US$ 76.43 Million in 2023, projecting it to reach US$ 720.20 Million by 2031. This translates to a CAGR of approximately 32.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Medical Exoskeleton Market report typically cover these key segments-

  • 组件 (硬件和软件)
  • 类型 (动力外骨骼和被动外骨骼)
  • 肢体 (下肢外骨骼, 上肢外骨骼, 全身外骨骼)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Medical Exoskeleton Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Exoskeleton Market report:

  • Historic Period : 2020-2021
  • Base Year : 2023
  • Forecast Period : 2023-2031
  • Who are the major players in Asia Pacific Medical Exoskeleton Market?

    The Asia Pacific Medical Exoskeleton Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Myomo Inc
  • Rex Bionics Ltd.
  • Who should buy this report?

    The Asia Pacific Medical Exoskeleton Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Exoskeleton Market value chain can benefit from the information contained in a comprehensive market report.